Jennifer J. Rhodes

2022

In 2022, Jennifer J. Rhodes earned a total compensation of $773.7K as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$12,200
Option Awards$320,613
Salary$440,840
Total$773,653

Rhodes received $440.8K in salary, accounting for 57% of the total pay in 2022.

Rhodes also received $12.2K in non-equity incentive plan and $320.6K in option awards.

Rankings

In 2022, Jennifer J. Rhodes' compensation ranked 3,576th out of 5,760 executives tracked by ExecPay. In other words, Rhodes earned more than 37.9% of executives.

ClassificationRankingPercentile
All
3,576
out of 5,760
38th
Division
Manufacturing
2,032
out of 3,136
35th
Major group
Chemicals And Allied Products
974
out of 1,422
32nd
Industry group
Drugs
911
out of 1,323
31st
Industry
Pharmaceutical Preparations
664
out of 969
32nd
Source: SEC filing on September 27, 2024.

Rhodes' colleagues

We found three more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2022.

2022

Jay Venkatesan

Elicio Therapeutics

Chief Executive Officer

2022

Robert Connelly

Elicio Therapeutics

Chief Executive Officer

2022

Christopher Haqq

Elicio Therapeutics

Chief Medical Officer

News

You may also like